DECEMBER 7 / 17.00 CET
Together with our partner Brain Research Center, we present the webinar:
Innovative Endpoints in Alzheimer’s Disease Clinical Trials.
We are pleased to announce that this webinar will be presented by:
Dr. Niels Prins and Dr. Jort Vijverberg.
Dr. Niels Prins and Dr. Jort Vijverberg will expand on how we advance clinical drug development for Alzheimer’s disease by touching upon:
> Biomarker-based participant selection in AD trials
> Fluid biomarkers as endpoints in AD trials.
> EEG; a ‘novel’ AD biomarker.
Don’t miss this opportunity and register now.